Medistim ASA (FRA:MD1)

Market Cap	330.37M
Revenue (ttm)	53.11M
Net Income (ttm)	10.81M
Shares Out	n/a
EPS (ttm)	n/a
PE Ratio	30.57
Forward PE	35.89
Dividend	0.51 (3.64%)
Ex-Dividend Date	May 9, 2025

Volume	75
Average Volume	34
Open	16.80
Previous Close	16.45
Day's Range	16.80 - 17.80
52-Week Range	11.10 - 17.80
Beta	n/a
RSI	79.02
Earnings Date	May 9, 2025

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1984
• Employees: 154
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: MD1

Financial Performance

In 2024, Medistim ASA's revenue was 556.16 million, an increase of 6.73% compared to the previous year's 521.11 million. Earnings were 103.83 million, an increase of 0.01%.

Financial numbers in NOK